{"DataElement":{"publicId":"6617855","version":"1","preferredName":"Leukemia Diagnosis Morphologic Finding Response Status","preferredDefinition":"Text term to describe the disease status based on morphologic evaluation.","longName":"LEUK_DX_MFR_ST","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"2014689","version":"1","preferredName":"Leukemia Diagnosis","preferredDefinition":"information related to the diagnosis of leukemia.","longName":"LEUK_DX","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2177113","version":"1","preferredName":"Leukemia","preferredDefinition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood.  Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present.  Leukemia is usually associated with anemia, fever, hemorrhagic episodes and splenomegaly.  Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia.  Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years. -- 2004","longName":"Leukemia","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7A87-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177541","version":"1","preferredName":"Diagnosis","preferredDefinition":"The process of identifying a disease by the signs and symptoms.","longName":"Diagnosis","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-51C6-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCEF491E-9072-3550-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-05-05","endDate":null,"createdBy":"PWEST","dateCreated":"2003-05-05","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6617852","version":"1","preferredName":"Morphologic Finding Response Status","preferredDefinition":"A light microscopic finding that describes the cellular characteristics and architectural patterns of cell populations in a tissue sample._The pathologic and/or clinical changes that result from treatment. The changes may refer to eradication of detectable disease, stabilization of disease, or disease progression._A condition or state at a particular time.","longName":"6617852v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Complete remission (CR with MRD or unknown)","valueDescription":"Complete Remission With Minimal Residual Disease Or Unknown","ValueMeaning":{"publicId":"6618529","version":"1","preferredName":"Complete Remission With Minimal Residual Disease Or Unknown","longName":"6618529","preferredDefinition":"The disappearance of all signs of cancer in response to treatment.: Used to indicate the presence of something or someone.: Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Measurable Residual Disease","conceptCode":"C3896","definition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8034EA61-0A42-1B02-E053-F662850AA473","latestVersionIndicator":"Yes","beginDate":"2019-01-24","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-24","modifiedBy":"ONEDATA","dateModified":"2019-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8034EA61-0A5D-1B02-E053-F662850AA473","beginDate":"2019-01-24","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-24","modifiedBy":"ONEDATA","dateModified":"2019-01-24","deletedIndicator":"No"},{"value":"Complete remission without MRD","valueDescription":"Complete Remission Without Minimal Residual Disease","ValueMeaning":{"publicId":"3855479","version":"1","preferredName":"Complete Remission Without Minimal Residual Disease","longName":"3855479","preferredDefinition":"The disappearance of all signs of cancer in response to treatment.: Used to indicate the absence or lack of something or someone. (from Merriam-Webster OnLine): remainder of a tumor or a neoplasm/cancer after primary, potentially curative therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Without","conceptCode":"C25718","definition":"Used to indicate the absence or lack of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Measurable Residual Disease","conceptCode":"C3896","definition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3F05B4C-B061-99BA-E040-BB89AD4372F4","latestVersionIndicator":"Yes","beginDate":"2013-08-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"800DEA32-E107-5B5A-E053-F662850AA5D1","beginDate":"2019-01-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-22","modifiedBy":"ONEDATA","dateModified":"2019-01-22","deletedIndicator":"No"},{"value":"Stable Disease","valueDescription":"Stable Disease","ValueMeaning":{"publicId":"2982985","version":"1","preferredName":"Stable Disease","longName":"2982985","preferredDefinition":"Cancer that is neither decreasing nor increasing in extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stable Disease","conceptCode":"C18213","definition":"A disease that is neither decreasing nor increasing in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C991ADD-0176-711A-E040-BB89AD432C85","latestVersionIndicator":"Yes","beginDate":"2010-01-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-01-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"800DEA32-E111-5B5A-E053-F662850AA5D1","beginDate":"2019-01-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-22","modifiedBy":"ONEDATA","dateModified":"2019-01-22","deletedIndicator":"No"},{"value":"Primary Refractory disease","valueDescription":"Primary Refractory Disease","ValueMeaning":{"publicId":"6617853","version":"1","preferredName":"Primary Refractory Disease","longName":"6617853","preferredDefinition":"Occurring first in time or sequence; original; of greatest rank or importance or value.: A disease that resists treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Refractory Disease","conceptCode":"C39752","definition":"A disease that resists treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"800DEA32-E11B-5B5A-E053-F662850AA5D1","latestVersionIndicator":"Yes","beginDate":"2019-01-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-22","modifiedBy":"ONEDATA","dateModified":"2019-01-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"800DEA32-E134-5B5A-E053-F662850AA5D1","beginDate":"2019-01-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-22","modifiedBy":"ONEDATA","dateModified":"2019-01-22","deletedIndicator":"No"},{"value":"Morphologic leukemia-free state(MLFS)","valueDescription":"Morphologic Leukemia - Free State","ValueMeaning":{"publicId":"2581112","version":"1","preferredName":"Morphologic Leukemia - Free State","longName":"2581112","preferredDefinition":"The disappearance of all cells with morphologic characteristics of leukemia, accompanied by bone marrow recovery, in response to treatment. Hematologic recovery is not required. Leukemia free state can be a hypocellular marrow.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Morphologic Leukemia-Free State","conceptCode":"C123597","definition":"The disappearance of all cells with morphologic characteristics of leukemia, accompanied by bone marrow recovery, in response to treatment. Hematologic recovery is not required. Leukemia free state can be a hypocellular marrow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-09E5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-10-02","modifiedBy":"COOPERM","dateModified":"2018-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8035540F-C724-1D11-E053-F662850A9CF3","beginDate":"2019-01-24","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-24","modifiedBy":"ONEDATA","dateModified":"2019-01-24","deletedIndicator":"No"},{"value":"Partial Remission","valueDescription":"Partial Remission","ValueMeaning":{"publicId":"3951935","version":"1","preferredName":"Partial Remission","longName":"3951935","preferredDefinition":"A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Partial Remission","conceptCode":"C18058","definition":"A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB155E17-C5B7-CEC3-E040-BB89AD4342C2","latestVersionIndicator":"Yes","beginDate":"2013-11-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454DF3A-F799-139F-E053-F662850A0C59","beginDate":"2019-10-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"Recovery","valueDescription":"Recovery","ValueMeaning":{"publicId":"2575938","version":"1","preferredName":"Recovery","longName":"2575938","preferredDefinition":"A healing process and/or an outcome implying relative health. The term is typically used in the context of direct and indirect effects of sickness or injury.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recovery","conceptCode":"C25746","definition":"A healing process and/or an outcome implying relative health.  The term is typically used in the context of direct and indirect effects of sickness or injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F5AF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-13","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2005-08-13","modifiedBy":"REEVESD","dateModified":"2006-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454DF3A-F783-139F-E053-F662850A0C59","beginDate":"2019-10-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"Progressive Disease","valueDescription":"Progressive Disease","ValueMeaning":{"publicId":"3284666","version":"1","preferredName":"Progressive Disease","longName":"3284666v1.00","preferredDefinition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD9FC7D6-531D-BE97-E040-BB89AD437875","latestVersionIndicator":"Yes","beginDate":"2011-09-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-23","modifiedBy":"MMADDINENI","dateModified":"2024-02-22","changeDescription":null,"administrativeNotes":"2023.5.17 Alt VM added per ticket request CADSR0002435. ak \r\n2023.3.15 Per LS at COG Protocol defined progressive disease (should have been added as a VM Alt Name for PV 3284666). ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454DF3A-F78E-139F-E053-F662850A0C59","beginDate":"2019-10-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"Complete Remission with Incomplete Hematologic","valueDescription":"Complete Remission with Incomplete Hematological Recovery","ValueMeaning":{"publicId":"6301226","version":"1","preferredName":"Complete Remission with Incomplete Hematological Recovery","longName":"6301226","preferredDefinition":"The disappearance of all signs of cancer in response to treatment with residual neutropenia (less than 1,000 per microliter), with or without complete platelet recovery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Remission with Incomplete Hematological Recovery","conceptCode":"C150587","definition":"The disappearance of all signs of leukemia in response to treatment with residual neutropenia (less than 1,000 per microliter), with or without complete platelet recovery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CE9F570-777C-3409-E053-F662850A610A","latestVersionIndicator":"Yes","beginDate":"2018-05-23","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-05-23","modifiedBy":"ONEDATA","dateModified":"2018-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454DF3A-F7AD-139F-E053-F662850A0C59","beginDate":"2019-10-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"Death Due to Inderterminate Cause","valueDescription":"Dead Due To Etiology","ValueMeaning":{"publicId":"6973081","version":"1","preferredName":"Dead Due To Etiology","longName":"6973081","preferredDefinition":"The cessation of life.: Expected or scheduled.: Used as a function word to indicate direction, purpose, or movement.: The cause of a disease or abnormal condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dead","conceptCode":"C28554","definition":"The cessation of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Due","conceptCode":"C45263","definition":"Expected or scheduled.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Etiology","conceptCode":"C16390","definition":"The cause of a disease or abnormal condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9454DF3A-F7DD-139F-E053-F662850A0C59","latestVersionIndicator":"Yes","beginDate":"2019-10-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454DF3A-F7F8-139F-E053-F662850A0C59","beginDate":"2019-10-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"Death in Aphasia","valueDescription":"Death in Aphasia","ValueMeaning":{"publicId":"6973082","version":"1","preferredName":"Death in Aphasia","longName":"6973082","preferredDefinition":"Death in Aphasia","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9454DF3A-F802-139F-E053-F662850A0C59","latestVersionIndicator":"Yes","beginDate":"2019-10-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454DF3A-F81B-139F-E053-F662850A0C59","beginDate":"2019-10-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"Molecular Relapse (after CR MRD)","valueDescription":"Molecular Relapse (after CR MRD)","ValueMeaning":{"publicId":"6973083","version":"1","preferredName":"Molecular Relapse (after CR MRD)","longName":"6973083","preferredDefinition":"Molecular Relapse (after CR MRD)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9454DF3A-F825-139F-E053-F662850A0C59","latestVersionIndicator":"Yes","beginDate":"2019-10-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454DF3A-F83E-139F-E053-F662850A0C59","beginDate":"2019-10-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"Hematologic Relapse (after CR MRD-, CR, CRi)","valueDescription":"Hematologic Relapse (after CR MRD-, CR, CRi)","ValueMeaning":{"publicId":"6973084","version":"1","preferredName":"Hematologic Relapse (after CR MRD-, CR, CRi)","longName":"6973084","preferredDefinition":"Hematologic Relapse (after CR MRD-, CR, CRi)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9454DF3A-F848-139F-E053-F662850A0C59","latestVersionIndicator":"Yes","beginDate":"2019-10-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454DF3A-F861-139F-E053-F662850A0C59","beginDate":"2019-10-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3865327","version":"1","preferredName":"Morphologic Finding Response Status","preferredDefinition":"A light microscopic finding that describes the cellular characteristics and architectural patterns of cell populations in a tissue sample.:The pathologic and/or clinical changes that result from treatment. The changes may refer to eradication of detectable disease, stabilization of disease, or disease progression.:A condition or state at a particular time.","longName":"C35867:C50995:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Morphologic Finding","conceptCode":"C35867","definition":"A light microscopic finding that describes the cellular characteristics and architectural patterns of cell populations in a tissue sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4E2F160-F279-E72E-E040-BB89AD430752","latestVersionIndicator":"Yes","beginDate":"2013-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-26","modifiedBy":"ONEDATA","dateModified":"2013-08-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"800DEA32-E0E8-5B5A-E053-F662850AA5D1","latestVersionIndicator":"Yes","beginDate":"2019-01-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-22","modifiedBy":"SOKKERL","dateModified":"2019-10-07","changeDescription":"1/22/19 ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Morphologic Status","type":"Preferred Question Text","description":"Morphologic Status","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"800DEA32-E177-5B5A-E053-F662850AA5D1","latestVersionIndicator":"Yes","beginDate":"2019-01-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-22","modifiedBy":"SOKKERL","dateModified":"2019-01-24","changeDescription":"1/22/19 ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}